ConductScience.org, home

Paper34130596

Epigenetic Editing in Prostate Cancer: Challenges and Opportunities.

Pacheco MB and 3 others. Epigenetics, 2022. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Epigenetic Editing in Prostate Cancer: Challenges and Opportunities. Papers, record 34130596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34130596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Epigenetic Editing in Prostate Cancer: Challenges and Opportunities.
PubMed
Journal
Epigenetics
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2022-07-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pacheco MBMariana Brütt
2Camilo VVânia
3Henrique RRuihttps://orcid.org/0000-0003-3171-4666
4Jerónimo CCarmenhttps://orcid.org/0000-0003-4186-5345

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene EditingMajor topic
Prostatic NeoplasmsMajor topic
CRISPR-Cas Systems
Chromatin
DNA Methylation
Epigenesis, Genetic
Humans
Male

Source PubMed

Download CSV of topics

References253

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124108092Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins.Nat Biotechnol2013https://conductscience.org/library/papers/24108092PubMed
232097843Novel approach to therapeutic targeting of castration-resistant prostate cancer.Med Hypotheses2020https://conductscience.org/library/papers/32097843PubMed
324793694A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.Mol Cell2014https://conductscience.org/library/papers/24793694PubMed
426000489Integrative clinical genomics of advanced prostate cancer.Cell2015https://conductscience.org/library/papers/26000489PubMed
526025803Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators.Genome Res2015https://conductscience.org/library/papers/26025803PubMed
623546521The future of epigenetic therapy in solid tumours--lessons from the past.Nat Rev Clin Oncol2013https://conductscience.org/library/papers/23546521PubMed
733414404Prostate apoptosis response-4 and tumor suppression: it's not just about apoptosis anymore.Cell Death Dis2021https://conductscience.org/library/papers/33414404PubMed
819933107Breaking the code of DNA binding specificity of TAL-type III effectors.Science2009https://conductscience.org/library/papers/19933107PubMed
921764166Histone modification: cause or cog?Trends Genet2011https://conductscience.org/library/papers/21764166PubMed
1028624514Bromodomain-containing proteins in prostate cancer.Mol Cell Endocrinol2018https://conductscience.org/library/papers/28624514PubMed
1131901636Sharpening the Molecular Scissors: Advances in Gene-Editing Technology.iScience2020https://conductscience.org/library/papers/31901636PubMed
1227272384Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells.Nat Biotechnol2016https://conductscience.org/library/papers/27272384PubMed
1322120715Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion.Oncogene2012https://conductscience.org/library/papers/22120715PubMed
1423892898CRISPR RNA-guided activation of endogenous human genes.Nat Methods2013https://conductscience.org/library/papers/23892898PubMed
1517962565A bacterial effector acts as a plant transcription factor and induces a cell size regulator.Science2007https://conductscience.org/library/papers/17962565PubMed
162443238Hypomethylation of DNA in pathological conditions of the human prostate.Cancer Res1987https://conductscience.org/library/papers/2443238PubMed
1718507002DNA damage response in prostate cancer cells after high-intensity focused ultrasound (HIFU) treatment.Anticancer Res2008https://conductscience.org/library/papers/18507002PubMed
1831053162Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.Epigenetics Chromatin2019https://conductscience.org/library/papers/31053162PubMed
1926066060Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing.Sci Rep2015https://conductscience.org/library/papers/26066060PubMed
2030640437Precision Control of CRISPR-Cas9 Using Small Molecules and Light.Biochemistry2019https://conductscience.org/library/papers/30640437PubMed

See all 253 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
40722714Unlocking the Role of OCT4 in Cancer Lineage Plasticity: A Cross-Cancer Perspective with an Emphasis on Prostate Cancer.Biomedicines2025https://conductscience.org/library/papers/40722714PubMed
40694614Epigenetic alterations in prostate cancer: the role of chromatin remodeling.Epigenomics2025https://conductscience.org/library/papers/40694614PubMed
40600050Precision scalpels for the epigenome: next-gen editing tools in targeted therapies.Front Med (Lausanne)2025https://conductscience.org/library/papers/40600050PubMed
39820138Prostate cancer epigenetics - from pathophysiology to clinical application.Nat Rev Urol2025https://conductscience.org/library/papers/39820138PubMed
38102645The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing.Cell Commun Signal2023https://conductscience.org/library/papers/38102645PubMed
37228649H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets.Front Cell Dev Biol2023https://conductscience.org/library/papers/37228649PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34130596

GET https://conductscience.org/api/papers/v1/34130596/references?page=2